Ultrasound and MRI in the diagnosis of penile induration (Peyronie's Disease)

1992 ◽  
Vol 2 (3) ◽  
pp. 230-232 ◽  
Author(s):  
G. Helweg ◽  
W. Judmaier ◽  
K. Wicke ◽  
A. Oberhauser ◽  
D. zur Nedden ◽  
...  
Keyword(s):  
Peyronie’S Disease ◽  
Penile Induration ◽  
Peyronie's Disease

Value of Magnetic Resonance Imaging in Patients With Penile Induration (Peyronie's Disease)

1995 ◽  
pp. 1122-1125 ◽  
Author(s):  
Rolf Vosshenrich ◽  
Immo Schroeder-Printzen ◽  
Wolfgang Weidner ◽  
Uwe Fischer ◽  
Matthias Funke ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Peyronie’S Disease ◽  
Resonance Imaging ◽  
Penile Induration ◽  
Peyronie's Disease

Value of Magnetic Resonance Imaging in Patients With Penile Induration (Peyronie's Disease)

1995 ◽  
Vol 153 (4) ◽  
pp. 1122-1125 ◽  
Author(s):  
Rolf Vosshenrich ◽  
Immo Schroeder-Printzen ◽  
Wolfgang Weidner ◽  
Uwe Fischer ◽  
Matthias Funke ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Peyronie’S Disease ◽  
Resonance Imaging ◽  
Penile Induration ◽  
Peyronie's Disease

scholarly journals EXPERIENCE OF COMBINING PLATELET-RICH AUTOPLASM THERAPY AND LOW-INTENSITY SHOCK-WAVE THERAPY IN TREATMENT OF PEYRONIE’S DISEASE

2019 ◽  
pp. 12-18
Author(s):  
Юрий Заседа
Keyword(s):  
Growth Factors ◽  
Peyronie’S Disease ◽  
Health Clinic ◽  
Penile Induration ◽  
Combined Use ◽  
Reduction Of Pain ◽  
Icd 10 ◽  
Peyronie's Disease ◽  
Therapeutic Model

Relevance. The spectrum of combined mechanisms of action of PRP-therapy, LISWT and LNP therapy suggests the clinical eff ect for patients with fi broplastic penile induration, which currently does not have conservative therapies that have suffi cient effi cacy.The aim of the study was to determine the effi cacy of combined PRP-therapy with intracavernous activation of growth factors by LISWT method + LNP and ICA pharmacotherapy in treatment of fi broplastic penile induction.Design. The study group comprised 23 patients of the Men’s Health Clinic in Kyiv, suff ering from fi broplastic penile inducing (Peyronie’s disease, ICD-10: N48.6) with erectile dysfunction.Results of the study. A 6-month follow-up observation showed a reduction of pain during erection, a signifi cant improvement in erectile function, a total regression of the areas less than 25 mm2 and a signifi cant decrease in the density and area of the induration areas that over 25 mm2. Conclusions. It has been established that the therapeutic model of the combined use of PRP-therapy with intracavernous activation of growth factors by LISWT method + LOD + ICA in the treatment of fi broplastic penile induration, shows a pronounced clinical eff ect, which makes this therapeutic model a promising option for conservative correction of pain and erectile dysfunction in fi broplastic penile induration.

scholarly journals Peyronie’s disease: A “triple oxygenant therapy”

2013 ◽  
Vol 85 (1) ◽  
pp. 36 ◽  
Author(s):  
Francesco Ciociola ◽  
Giovanni Maria Colpi
Keyword(s):  
Nitric Oxide ◽  
Peyronie’S Disease ◽  
Vitamin B3 ◽  
Caucasian Male ◽  
Mild Pain ◽  
Penile Induration ◽  
Ultrasound Evaluation ◽  
Septal Thickness ◽  
Cgmp Pathway ◽  
Peyronie's Disease

Objectives: To evaluate the effects of upregulators of nitric oxide in one patient with Peyronie’s disease, after non significant improvement following intracavernosal verapamil. Methods: A 20-years-old Caucasian male presented with penile induration in flaccid state, persistent during erection and associated with mild pain at third middle of penis. After treatment with intracavernosal verapamil for 4 months with relief of penile discomfort, followed by counseling on the use of penile extender for at least 6 hours per day, he was prescribed pentoxifylline associated with tadalafil plus levo-arginine, propionil-carnitine and Vitamin B3. Results: After almost 2 years, the septal thickness was reduced at ultrasound evaluation after this “triple oxygenant therapy”. Conclusion: NO-iNOS biology in Peyronie patients is the very protagonist in modulating penile fibrosis through up-regulation of NO-cGMP pathway that influences penile health by preventing and reversing fibrosis in the tunical albuginea.

1058: The Effect of Pentoxifylline on Cultured Human Tunical Fibroblasts from Patients with Peyronie's Disease

2005 ◽  
Vol 173 (4S) ◽  
pp. 287-287
Author(s):  
Thomas X. Minor ◽  
Guiting Lin ◽  
Amr Jad ◽  
Ching-Shwun Lin ◽  
Narihiko Hayashi ◽  
...  
Keyword(s):  
Peyronie’S Disease ◽  
Peyronie's Disease

1002: The Pathogenesis of Peyronie's Disease: Can Protein Expression Predict Progression

2006 ◽  
Vol 175 (4S) ◽  
pp. 323-323
Author(s):  
Gerald B. Brock ◽  
Ling De Young ◽  
Bing Siang Gan ◽  
Anthony J. Bella ◽  
Kok Bin Lim
Keyword(s):  
Protein Expression ◽  
Peyronie’S Disease ◽  
Peyronie's Disease

946: Management of Penile Fracture in Men with Peyronie's Disease

2005 ◽  
Vol 173 (4S) ◽  
pp. 256-256
Author(s):  
Thomas X. Minor ◽  
Nadeem U. Rahman ◽  
Tom F. Lue
Keyword(s):  
Peyronie’S Disease ◽  
Penile Fracture ◽  
Peyronie's Disease

943: Plasminogen Activator Inhibitor 1 (PAI-1) is Increased in Human Peyronie's Disease

2005 ◽  
Vol 173 (4S) ◽  
pp. 255-255 ◽  
Author(s):  
Hugo H. Davila ◽  
Thomas R. Magee ◽  
Freddy Zuniga ◽  
Jacob Rajfer ◽  
Nestor F. GonzalezCadavid
Keyword(s):  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Peyronie’S Disease ◽  
Plasminogen Activator Inhibitor 1 ◽  
Peyronie's Disease ◽  
Activator Inhibitor ◽  
Pai 1

936: Intralesional Verapamil Prevents Progression of Peyronie's Disease

2005 ◽  
Vol 173 (4S) ◽  
pp. 253-253 ◽  
Author(s):  
John P. Mulhall ◽  
Patricia Guhring ◽  
Christine Depierro
Keyword(s):  
Peyronie’S Disease ◽  
Peyronie's Disease
Sign in / Sign up

Export Citation Format

Share Document